Causes of Death. Our World in Data. https://ourworldindata.org/causes-of-death. Accessed 2 Aug 2023.

Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–54. https://doi.org/10.1016/s0140-6736(15)00516-4.

Article  PubMed  Google Scholar 

Prince MJ, Wu F, Guo Y, Gutierrez Robledo LM, O’Donnell M, Sullivan R, et al. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385(9967):549–62. https://doi.org/10.1016/s0140-6736(14)61347-7.

Article  PubMed  Google Scholar 

Golubnitschaja O, Kinkorova J, Costigliola V. Predictive, Preventive and personalised medicine as the hardcore of ‘Horizon 2020’: EPMA position paper. EPMA J. 2014;5(1):6. https://doi.org/10.1186/1878-5085-5-6.

Article  PubMed  PubMed Central  Google Scholar 

Wang W, Yan Y, Guo Z, Hou H, Garcia M, Tan X, et al. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive Preventive and Personalised Medicine. EPMA J. 2021;12(4):403–33. https://doi.org/10.1007/s13167-021-00253-2.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. EPMA J. 2016;7(1):23. https://doi.org/10.1186/s13167-016-0072-4.

Article  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Costigliola V. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J. 2012;3(1):14. https://doi.org/10.1186/1878-5085-3-14.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Deng X, Lin D, Yang P, Wu S, Wang X, et al. Predicting 1-, 3-, 5-, and 8-year all-cause mortality in a community-dwelling older adult cohort: relevance for predictive, preventive, and personalized medicine. EPMA J. 2023;14(4):713–26. https://doi.org/10.1007/s13167-023-00342-4.

Article  PubMed  PubMed Central  Google Scholar 

Tian Q, Chen S, Zhang J, Li C, Wu S, Wang Y, et al. Ideal cardiovascular health metrics and life expectancy free of cardiovascular diseases: a prospective cohort study. Epma j. 2023;14(2):185–99. https://doi.org/10.1007/s13167-023-00322-8.

Article  PubMed  Google Scholar 

Blackburn EH. Telomeres and telomerase: their mechanisms of action and the effects of altering their functions. FEBS Lett. 2005;579(4):859–62. https://doi.org/10.1016/j.febslet.2004.11.036.

Article  CAS  PubMed  Google Scholar 

Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193–8. https://doi.org/10.1126/science.aab3389.

Article  CAS  PubMed  Google Scholar 

d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426(6963):194-8 https://doi.org/10.1038/nature02118

Palm W, de Lange T. How shelterin protects mammalian telomeres. Annu Rev Genet. 2008;42:301–34. https://doi.org/10.1146/annurev.genet.41.110306.130350.

Article  CAS  PubMed  Google Scholar 

von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27(7):339–44. https://doi.org/10.1016/s0968-0004(02)02110-2.

Article  Google Scholar 

Deng Y, Li Q, Zhou F, Li G, Liu J, Lv J, et al. Telomere length and the risk of cardiovascular diseases: a Mendelian randomization study. Front Cardiovasc Med. 2022;9:1012615. https://doi.org/10.3389/fcvm.2022.1012615.

Article  PubMed  PubMed Central  Google Scholar 

Hunt SC, Kark JD, Aviv A. Association between shortened leukocyte telomere length and cardio-metabolic outcomes. Circ Cardiovasc Genet. 2015;8(1):4–7. https://doi.org/10.1161/circgenetics.114.000964.

Article  PubMed  Google Scholar 

Rossiello F. Jurk D, Passos JF, d’Adda di Fagagna F Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol. 2022;24(2):135–47. https://doi.org/10.1038/s41556-022-00842-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng F, Carroll L, Joglekar MV, Januszewski AS, Wong KK, Hardikar AA, et al. Diabetes, metabolic disease, and telomere length. Lancet Diabetes Endocrinol. 2021;9(2):117–26. https://doi.org/10.1016/s2213-8587(20)30365-x.

Article  CAS  PubMed  Google Scholar 

Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304(1):69–75. https://doi.org/10.1001/jama.2010.897.

Article  CAS  PubMed  Google Scholar 

Reddel RR. Telomere maintenance mechanisms in cancer: clinical implications. Curr Pharm Des. 2014;20(41):6361–74. https://doi.org/10.2174/1381612820666140630101047.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schneider CV, Schneider KM, Teumer A, Rudolph KL, Hartmann D, Rader DJ, et al. Association of telomere length with risk of disease and mortality. JAMA Intern Med. 2022;182(3):291–300. https://doi.org/10.1001/jamainternmed.2021.7804.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62. https://doi.org/10.1016/s0140-6736(12)62167-9.

Article  PubMed  Google Scholar 

Chen X, Mao G, Leng SX. Frailty syndrome: an overview. Clin Interv Aging. 2014;9:433–41. https://doi.org/10.2147/cia.S45300.

Article  PubMed  PubMed Central  Google Scholar 

Cesari M, Gambassi G, van Kan GA, Vellas B. The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing. 2014;43(1):10–2. https://doi.org/10.1093/ageing/aft160.

Article  PubMed  Google Scholar 

Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56. https://doi.org/10.1093/gerona/56.3.m146.

Article  CAS  PubMed  Google Scholar 

Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;3(7):e323–32. https://doi.org/10.1016/s2468-2667(18)30091-4.

Article  PubMed  PubMed Central  Google Scholar 

Brunner-La Rocca HP, Fleischhacker L, Golubnitschaja O, Heemskerk F, Helms T, Hoedemakers T, et al. Challenges in personalised management of chronic diseases-heart failure as prominent example to advance the care process. EPMA J. 2015;7(1):2. https://doi.org/10.1186/s13167-016-0051-9.

Article  PubMed  Google Scholar 

Zubor P, Kubatka P, Kapustova I, Miloseva L, Dankova Z, Gondova A, et al. Current approaches in the clinical management of pregnancy-associated breast cancer-pros and cons. EPMA J. 2018;9(3):257–70. https://doi.org/10.1007/s13167-018-0139-5.

Article  PubMed  PubMed Central  Google Scholar 

Kucera R, Pecen L, Topolcan O, Dahal AR, Costigliola V, Giordano FA, et al. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11(3):399–418. https://doi.org/10.1007/s13167-020-00214-1.

Article  PubMed  PubMed Central  Google Scholar 

Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. https://doi.org/10.1371/journal.pmed.1001779.

Article  PubMed  PubMed Central  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573–7. https://doi.org/10.7326/0003-4819-147-8-200710160-00010.

Article  Google Scholar 

Codd V, Denniff M, Swinfield C, Warner SC, Papakonstantinou M, Sheth S, et al. Measurement and initial characterization of leukocyte telomere length in 474,074 participants in UK Biobank. Nat Aging. 2022;2(2):170–9. https://doi.org/10.1038/s43587-021-00166-9.

Article  CAS  PubMed  Google Scholar 

Williams DM, Jylhävä J, Pedersen NL, Hägg S. A frailty index for UK Biobank participants. J Gerontol A Biol Sci Med Sci. 2019;74(4):582–7. https://doi.org/10.1093/gerona/gly094.

Article  PubMed  Google Scholar 

Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. https://doi.org/10.1186/1471-2318-8-24.

Article  PubMed  PubMed Central  Google Scholar 

Cao X, Li X, Zhang J, Sun X, Yang G, Zhao Y, et al. Associations between frailty and the increased risk of adverse outcomes among 38,950 UK Biobank participants with prediabetes: prospective cohort study. JMIR Public Health Surveill. 2023;9:e45502. https://doi.org/10.2196/45502.

Article  PubMed